167 related articles for article (PubMed ID: 18215435)
1. Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial.
Ringash J; Lockwood G; O'Sullivan B; Warde P; Bayley A; Cummings B; Kim J; Sellmann S; Waldron J
Radiother Oncol; 2008 May; 87(2):181-7. PubMed ID: 18215435
[TBL] [Abstract][Full Text] [Related]
2. A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.
Waldron J; Warde P; Irish J; Pintilie M; Sellmann S; Bayley A; Cummings B; Kim J; Liu FF; Payne D; Ringash J; Brown D; Freeman J; Gilbert R; Gullane P; Witterick I; O'Sullivan B
Radiother Oncol; 2008 May; 87(2):173-80. PubMed ID: 18342965
[TBL] [Abstract][Full Text] [Related]
3. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
4. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
[TBL] [Abstract][Full Text] [Related]
5. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
6. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
[TBL] [Abstract][Full Text] [Related]
7. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
9. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.
El-Deiry M; Funk GF; Nalwa S; Karnell LH; Smith RB; Buatti JM; Hoffman HT; Clamon GH; Graham SM; Trask DK; Dornfeld KJ; Yao M
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):879-85. PubMed ID: 16230590
[TBL] [Abstract][Full Text] [Related]
10. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.
Cummings B; Keane T; Pintilie M; Warde P; Waldron J; Payne D; Liu FF; Bissett R; McLean M; Gullane P; O'Sullivan B
Radiother Oncol; 2007 Oct; 85(1):7-16. PubMed ID: 17920715
[TBL] [Abstract][Full Text] [Related]
11. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
[TBL] [Abstract][Full Text] [Related]
12. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
[TBL] [Abstract][Full Text] [Related]
14. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.
Ravasco P; Monteiro-Grillo I; Marques Vidal P; Camilo ME
Head Neck; 2005 Aug; 27(8):659-68. PubMed ID: 15920748
[TBL] [Abstract][Full Text] [Related]
15. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.
Fang FM; Tsai WL; Chien CY; Chiu HC; Wang CJ; Chen HC; Hsiung CY
Oncology; 2005; 68(4-6):405-13. PubMed ID: 16020970
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
17. Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy.
O'Neill M; Heron DE; Flickinger JC; Smith R; Ferris RL; Gibson M
Am J Clin Oncol; 2011 Oct; 34(5):478-82. PubMed ID: 21537150
[TBL] [Abstract][Full Text] [Related]
18. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
Ohno T; Nakano T; Kato S; Koo CC; Chansilpa Y; Pattaranutaporn P; Calaguas MJ; de Los Reyes RH; Zhou B; Zhou J; Susworo R; Supriana N; Dung TA; Ismail F; Sato S; Suto H; Kutsutani-Nakamura Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1522-9. PubMed ID: 17919839
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
[TBL] [Abstract][Full Text] [Related]
20. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy.
Fang FM; Chien CY; Kuo SC; Chiu HC; Wang CJ
Acta Oncol; 2004; 43(6):571-8. PubMed ID: 15370615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
